The evolution of cardiovascular COVID-19 research
Eur Heart J
.
2021 Aug 7;42(30):2953-2954.
doi: 10.1093/eurheartj/ehab240.
Authors
Tushar Kotecha
1
2
,
Daniel S Knight
1
2
,
James C Moon
2
3
,
Graham D Cole
4
5
,
Marianna Fontana
1
6
Affiliations
1
Department of Cardiology, Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, UK.
2
Institute of Cardiovascular Science, University College London, London WC1e 6DD, UK.
3
Department of Cardiovascular Magnetic Resonance, Barts Heart Centre, Barts Health NHS Trust, West Smithfield, London EC1A 7BE, UK.
4
Department of Cardiology, Imperial Healthcare NHS Trust, Du Cane Road, London W12 0HS, UK.
5
National Heart and Lung Institute, Imperial College London, Du Cane Road, London W12 0NN, UK.
6
National Amyloidosis Centre, Division of Medicine, University College London, Rowland Hill Street, London NW3 2PF, UK.
PMID:
34166510
PMCID:
PMC8344642
DOI:
10.1093/eurheartj/ehab240
No abstract available
Publication types
Comment
MeSH terms
COVID-19*
Cardiovascular Diseases*
Cardiovascular System*
Humans
SARS-CoV-2
Grants and funding
FS/18/21/33447/BHF_/British Heart Foundation/United Kingdom